FDA requests comments on draft guidances for Precision Medicine Initiative

The U.S. Food and Drug Administration (FDA) has announced two draft guidances to support President Obama's Precision Medicine Initiative. The guidances will help provide oversight for tests based on next generation sequencing, a technology that examines a person's DNA to detect medically important differences in genomic make-up that could increase the risk for disease.
Source: NHGRI Homepage Highlights - Category: Genetics & Stem Cells Source Type: news